The Pathology Coordinating Office has been in operation at Roswell Park Memorial Institute since November 1979. The number of studies in which the Pathology Committee has participated, either in development or central histology review includes ten protocols for malignant lymphoma, six for lung cancer, and one for head and neck cancer. Fourteen educational sessions and three workshops have been presented. This proposal is for appropriate support for the Pathology Coordinating Office to continue to enhace its effectiveness in group activities. This is to be accomplished through (1) the monitoring of pathology input into protocol development, (2) the supervision of the quality control and prompt central reviewing of the histologic material submitted, (3) the assessment of the impact of the effort by group pathologists in the outcome of protocol studies, and (4) the implementation of immunohistochemical assays in three laboratories for tumor-associated or mouse mammary tumor virus-associated antigens in Stage II breast carcinoma (Protocol 8082) for correlation with estrogen-receptor and menopausal status as well as response to chemotherapy.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA037055-03
Application #
3557955
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1984-04-01
Project End
1988-03-31
Budget Start
1986-04-01
Budget End
1987-03-31
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Cooper, G S; Kamel, F; Sandler, D P et al. (1996) Risk of adult acute leukemia in relation to prior immune-related conditions. Cancer Epidemiol Biomarkers Prev 5:867-72
Stone, R M; Berg, D T; George, S L et al. (1995) Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B. N Engl J Med 332:1671-7
Liu, E; Thor, A; He, M et al. (1992) The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast. Oncogene 7:1027-32
Davey, F R; Lawrence, D; MacCallum, J et al. (1992) Morphologic characteristics of acute lymphoblastic leukemia (ALL) with abnormalities of chromosome 8, band q24. Am J Hematol 40:183-91
Elghetany, M T; Sullivan, A K; Kurec, A S et al. (1992) The use of monoclonal antibodies against primary myeloid granules in normal and leukemic cells. Am J Clin Pathol 98:430-6
Ben-Ezra, J; Burke, J S; Swartz, W G et al. (1989) Small lymphocytic lymphoma: a clinicopathologic analysis of 268 cases. Blood 73:579-87
Davey, F R; Davis, R B; MacCallum, J M et al. (1989) Morphologic and cytochemical characteristics of acute promyelocytic leukemia. Am J Hematol 30:221-7